atherothrombosis compared with the rest of the world: Results from the
REduction of Atherothrombosis for Continued Health (REACH) Registry" S.
Goto, Y. Ikeda, JCN. Chan, PWF. Wilson, R. Zambahari, T-C. Yeo, C-S.
Liau, TB. Abola, PG. Steg, DL. Bhatt
-- "International variation in the rates of vascular hospitalizations in
patients at risk of atherothrombosis: Results from the REACH Registry
for U.S., France, and Germany" E M. Mahoney, K. Wang, DJ. Cohen, F.
Mosse, J. Jackson, DL. Bhatt, PG. Steg, G. De Pouvourville
-- "Cardiovascular risk profile and outcome of patients with an abdominal
aortic aneurysm in the REACH Registry" Baumgartner, AT. Hirsch, TB.
Abola, PP. Cacoub, D. Poldermans, PG. Steg, MA. Creager, K. Eagle, DL.
Objectives and Scope of REACH
The overall aim of the REACH Registry is to improve the assessment and management of stroke, heart attack and associated risk factors for atherothrombosis. It is the largest and most geographically extensive global registry of patients at risk of atherothrombosis, having recruited over 68,000 patients in 44 countries, covering six regions - Latin America, Asia, the Middle East, Australia, Europe and North America - and involving over 5,000 physician investigators.
The REACH Registry includes a broad spectrum of patients with atherothrombosis - documenting the health status and treatment of people at risk of atherothrombosis; monitoring how they are affected; and measuring the burden of the disease. Patients included in the REACH Registry either have several of the risk factors that can lead to atherothrombosis, such as, high cholesterol, high blood pressure, smoking, and diabetes, or have a previous history of heart attack, stroke or PAD. Participation in the REACH Registry is strictly voluntary.
In addition, the REACH Registry is based in a real-life setting and
|SOURCE REACH Registry|
Copyright©2007 PR Newswire.
All rights reserved